Restriction on import of certain pharmaceutical raw material
9. (1) No pharmaceutical raw material necessary for the manufacture of any medicine specified in any of the Schedules shall be imported.
(2) No drug [, semi-finished bulk drug] or pharmaceutical raw material shall be imported except with the prior approval of the licensing authority.
(3) The licensing authority may award an approval under sub-section (2) on such conditions as it deems fit to specify [:
Provided that in case of awarding approval to import any finished medicine, such medicine shall be registered for sale under the same brand name in any of the countries specified under sub-section (1A) of section 5.]
Copyright © 2019, Legislative and Parliamentary Affairs Division
Ministry of Law, Justice and Parliamentary Affairs